ADNEXUS

Biotechnology products for human and animal use, namely, human and veterinary vaccines for the treatment and prevention of diseases; Pharmaceutical products for human use for the treatment and prevention of diseases in the nature of the human immunodeficiency virus (HIV) and COVID-19.